Financializing epistemic norms in contemporary biomedical innovation.
The rapid, recent emergence of new medical knowledge models has engendered a dizzying number of new medical initiatives, programs and approaches. Fields such as evidence-based medicine and translational medicine all promise a renewed relationship between knowledge and medicine. The question for phil...
| Publicado en: | Synthese Vol. 196; no. 11; pp. 4391 - 4408 |
|---|---|
| Autor principal: | |
| Formato: | Artículo |
| Publicado: |
Springer Nature
Nov2019
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=hlh&AN=139254725&site=ehost-live header: @attributes: shortDbName: hlh uiTerm: 139254725 longDbName: Humanities International Complete uiTag: AN controlInfo: bkinfo: jinfo: jid: 00397857 4LI jtl: Synthese issn: 00397857 maglogo: N pubinfo: dt: Nov2019 vid: 196 iid: 11 pid: 237 pub: Springer Nature artinfo: ui: 139254725 10.1007/s11229-018-1704-0 ppf: 4391 ppct: 17 formats: fmt: – @attributes: type: T – @attributes: type: P size: 435KB tig: atl: Financializing epistemic norms in contemporary biomedical innovation. aug: au: Robinson, Mark D. affil: Department of Medical Education, School of Medicine, Center for Health Policy and Ethics Interdisciplinary Studies, Graduate School, Creighton University, Omaha, NE, USA su: Medical innovations Translational research Other (Philosophy) Electron work function Scientific models Medical informatics sug: subj: Medical innovations Translational research Other (Philosophy) Electron work function Scientific models Medical informatics keyword: Clinical translation Finance Funding Industry Pharmaceutical companies Science policy Social epistemology Translational medicine Translational science ab: The rapid, recent emergence of new medical knowledge models has engendered a dizzying number of new medical initiatives, programs and approaches. Fields such as evidence-based medicine and translational medicine all promise a renewed relationship between knowledge and medicine. The question for philosophy and other fields has been whether these new models actually achieve their promises to bring about better kinds of medical knowledge—a question that compels scholars to analyze each model's epistemic claims. Yet, these analyses may miss critical components that explain how these models actually work and function. Using the case of translational medicine, this paper suggests that analyses which treat these models as a primarily epistemic interventions miss the way that new approaches are increasingly shaped by specific financial and commercial agendas. Ultimately, social epistemological analyses that are attentive to market forces are required to make sense of emerging bioscientific research models, which are increasingly tethered to or a manifestation of increasingly financialized models of science research and innovation. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: Y custom: Synthese is a copyright of Springer, 2019. All Rights Reserved. item: Synthese holder: Springer Nature dt: @attributes: year: 2019 holdings: @attributes: islocal: N |
|---|